Correction: Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma (Journal of Experimental & Clinical Cancer Research, (2014), 33, 1, (114), 10.1186/s13046-014-0114-5);Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Zhu, Xin ^a   Xu, Jia Jie ^a   Hu, Si Si ^a   Feng, Jian Guo ^a   Jiang, Lie Hao ^a   Hou, Xiu Xiu ^a   Cao, Jun ^a   Han, Jing ^a   Ling, Zhi Qiang ^a   Ge, Ming Hua ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Pim 1; RUNX3; Salivary gland adenoid cystic carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; MESSENGER RNA; PROTEIN KINASE PIM 1; SGI 1776; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; PIM1 PROTEIN, HUMAN; RUNX3 PROTEIN, HUMAN; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL LINE; CANCER STAGING; CANCER TISSUE; CELL COUNTING KIT 8 ASSAY; CELL CYCLE ARREST; CELL INVASION; CELL MEMBRANE DEPOLARIZATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; OVERALL SURVIVAL; PIM 1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SACC 83 CELL LINE; SACC LM CELL LINE; SALIVARY GLAND CARCINOMA; TRANSWELL MIGRATION ASSAY; GENETICS; ONCOGENE; RNA INTERFERENCE; SALIVARY GLAND TUMOR; SURVIVAL ANALYSIS; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; HUMANS; ONCOGENES; PROTO-ONCOGENE PROTEINS C-PIM-1; RNA INTERFERENCE; RNA, SMALL INTERFERING; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84988484839     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-022-02509-9     Document Type: Erratum

References (29)

1. Moskaluk CA: Adenoid cystic carcinoma: clinical and molecular features. Head Neck Pathol 2013, 7(1):17-22.
2. Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK: Molecular biology of adenoid cystic carcinoma. Head Neck 2012, 34(11):1665-1677.
3. Gondivkar SM, Gadbail AR, Chole R, Parikh RV: Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral Oncol 2011, 47(4):231-236.
4. Chuang LS, Ito K, Ito Y, RUNX family: Regulation and diversification of roles through interacting proteins. Int J Cancer 2013, 132(6):1260-1271.
5. He JF, Ge MH, Zhu X, Chen C, Tan Z, Li YN, Gu ZY: Expression of RUNX3 in salivary adenoid cystic carcinoma: Implications for tumor progression and prognosis. Cancer Sci 2008, 99(7):1334-1340.
6. Ge MH, Ling ZQ, Tan Z, Chen C, Zheng CM, Xu JJ, Zhu X: RUNX3 expression and its methylation of 5'-CpG island in salivary gland adenoid cystic carcinoma cell lines ACC-2, ACC-3 and ACC-M. Zhonghua Yi Xue Za Zhi 2010, 90(48):3426-3430 (in Chinese).
7. Kim HR, Oh BC, Choi JK, Bae SC: Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization. J Cell Biochem 2008, 105(4):1048-1058.
8. Aho TL, Sandholm J, Peltola KJ, Ito Y, Koskinen PJ: Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity. BMC Cell Biol 2006, 7:21.
9. Nawijn MC, Alendar A, Berns A: For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer 2011, 11(1):23-34.
10. Magnuson NS, Wang Z, Ding G, Reeves R: Why target PIM1 for cancer diagnosis and treatment? Future Oncol 2010, 6(9):1461-1478.
11. Gao J, Wang L, Xu J, Zheng J, Man X, Wu H, Jin J, Wang K, Xiao H, Li S, Li Z: Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression. J Exp Clin Cancer Res 2013, 32:86.
12. Adamo R, Comandini A, Aquino A, Bonmassar L, Guglielmi L, Bonmassar E, Franzese O: The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro. J Exp Clin Cancer Res 2013, 32:38.
13. Lai XF, Shen CX, Wen Z, Qian YH, Yu CS, Wang JQ, Zhong PN, Wang HL: PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. J Exp Clin Cancer Res 2012, 31:12.
14. Dong L, Wang YX, Li SL, Yu GY, Gan YH, Li D, Wang CY: TGF-beta1 promotes migration and invasion of salivary adenoid cystic carcinoma. J Dent Res 2011, 90(6):804-809.
15. Li SL: Establishment of a human cancer cell line from adenoid cystic carcinoma of the minor salivary gland. Zhonghua Kou Qiang Yi Xue Za Zhi 1990, 25:29-31 (In Chinese).
16. Ling ZQ, Guo W, Lu XX, Zhu X, Hong LL, Wang Z, Chen Y: A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers. Ann Oncol 2014, 25(7):1363-1372.
17. Yan B, Yau EX, Samanta S, Ong CW, Yong KJ, Ng LK, Bhattacharya B, Lim KH, Soong R, Yeoh KG, Deng N, Tan P, Lam Y, Salto-Tellez M, Singapore Gastric Cancer Consortium: Clinical and therapeutic relevance of PIM1 kinase in gastric cancer. Gastric Cancer 2012, 15(2):188-197.
18. Kim J, Roh M, Abdulkadir SA: Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. BMC Cancer 2010, 10:248.
19. Li S, Xi Y, Zhang H, Wang Y, Wang X, Liu H, Chen K: A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation. Oncol Rep 2010, 24(4):997-1004.
20. Malinen M, Jääskeläinen T, Pelkonen M, Heikkinen S, Väisänen S, Kosma VM, Nieminen K, Mannermaa A, Palvimo JJ: Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors. Mol Cell Endocrinol 2013, 365(2):270-276.
21. Jin Y, Tong DY, Tang LY, Chen JN, Zhou J, Feng ZY, Shao CK: Expressions of Osteopontin (OPN), αíβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC). Chin J Cancer Res 2012, 24(2):103-108.
22. Weirauch U, Beckmann N, Thomas M, Grünweller A, Huber K, Bracher F, Hartmann RK, Aigner A: Functional role and therapeutic potential of the pim-1 kinase in colon carcinoma. Neoplasia 2013, 15(7):783-794.
23. Alvarado Y, Giles FJ, Swords RT: The PIM kinases in hematological cancers. Expert Rev Hematol 2012, 5(1):81-96.
24. Natarajan K, Bhullar J, Shukla S, Burcu M, Chen ZS, Ambudkar SV, Baer MR: The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms. Biochem Pharmacol 2013, 85(4):514-524.
25. Yang Q, Chen LS, Neelapu SS, Miranda RN, Medeiros LJ, Gandhi V: Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma. Blood 2012, 120(17):3491-3500.
26. Chen LS, Redkar S, Taverna P, Cortes JE, Gandhi V: Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia. Blood 2011, 118(3):693-702.
27. Li G, Zhang Z, Wang R, Ma W, Yang Y, Wei J, Wei Y: Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest. J Exp Clin Cancer Res 2013, 32:20.
28. Choi JY, Cho SI, Do NY, Kang CY, Lim SC: Clinical significance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg 2010, 39(1):28-34.
29. Peng YH, Li JJ, Xie FW, Chen JF, Yu YH, Ouyang XN, Liang HJ: Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients. PLoS One 2013, 8(10):e76693.